Informations générales (source: ClinicalTrials.gov)

NCT03684317 Statut inconnu
Primary Dependence to Analgesic Drugs: Development of a Predictive Approach Based on Early Modifications of Drug Use in the Ambulatory Care Setting (NEO-ADDICT)
Observational
  • Comportement toxicomaniaque
University Hospital, Toulouse (Voir sur ClinicalTrials)
juin 2019
avril 2023
03 août 2024
Abuse of analgesics represents an important part of prescription drug abuse. The consequences in terms of morbidity and mortality at the population level could reach worryingly high levels, as illustrated by the US context. This issue should not focus only on opioid analgesics, but must also account for some antiepileptics or antidepressants with abuse potential (for example, pregabalin or gabapentin). In France, reports related to tramadol abuse are increasing, in particular since dextropropoxyphene withdrawal. Trends of growing abuse are also reported for other analgesics. Patients with no history of primary dependence constituted a significant proportion of those developing a tramadol abuse. There is therefore a need for early identification of these patients and to raise awareness of health professionals on this issue, in particular in primary care. Given the extensive use of analgesic drugs in France, the problem of primary dependence should not be neglected. Since it will affect people who have no history of drug abuse, strategies for identification and prevention are differing from a population already using psychotropic products for example.
 Voir le détail

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
University Hospital toulouse - Toulouse - France Maryse Lapeyre-Mestre, MD PhD En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Subjects included in the SNIIRAM (French National inter-scheme health insurance
information system) database

- Age >18 at index date (date of first analgesic dispensing)

- At least three dispensing of analgesic drugs

- At least two years of available follow-up at the date of first analgesic dispensing
in the SNIIRAM database

- No dispensing for any of the analgesics of interest in the past 12 months (selection
of new users only)



- none